lansoprazole has been researched along with Bowel Diseases, Inflammatory in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, T | 1 |
| Sharma, A | 1 |
| Vyas, N | 1 |
| Gupta, P | 1 |
| Parikh, M | 1 |
| Shah, H | 1 |
1 other study available for lansoprazole and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat.
Topics: Animals; Colitis; Colon; Female; Inflammatory Bowel Diseases; Lansoprazole; Nitric Oxide; Oxidative | 2021 |